Dxcover Ltd. initiated three pivotal trials to measure the efficacy of its liquid biopsy platform for early detection of brain, colorectal and lung cancers. The company hopes the trials will provide the evidence needed to gain regulatory approval and begin commercial operations of its diagnostic technology in Europe and the U.S. Read More

In a potential godsend for women struggling with infertility and painful periods, Hera Biotech Inc. acquired the endometriosis diagnostic assets of Scailyte AG, consolidating the two leading tissue-based diagnostic programs for the disease. The combination of the companies’ non-surgical diagnostic options could significantly speed time to treatment for millions of women, who on average spend 10 years in search of the cause of chronic pelvic pain before being diagnosed with endometriosis. Read More

Sometimes a small change of wording has a big effect on the implications of a U.S. FDA guidance, a notion that may apply to the U.S. FDA’s final guidance for the use of computational modeling in device premarket submissions. Read More

The U.S. FDA issued a complete response letter to Shin Nippon Biomedical Laboratories Ltd.’s U.S. subsidiary, Satsuma Pharmaceuticals Inc., for its NDA for dihydroergotamine nasal powder (STS-101) for acute treatment of migraine, with or without aura, in adults. Shin Nippon acquired Satsuma for $220 million in April 2023 and gained rights to STS-101. Read More

A team of inventors predominantly based in the state of New York are seeking patent protection for an earbud system that integrates real-time electroencephalography (EEG) monitoring with audio playback. Using specialized silicone electrodes, it captures and interprets EEG data, serving as a passive and continuous tool for screening neurological conditions. Read More

New hires and promotions in the med-tech industry, including: Gemini Bioproducts, Medpharm, Meximed. Read More

Med-tech firms raising money in public or private financings, including: Epicore, RDS. Read More

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Dermtech. Read More

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbott, Bostongene, Caresyntax, Curonix, Cytek, Gimmi , Onward Medical, Novocure, Orthofix Medical, Painteq, Rescale, Sure Med, Total Scope, MC Healthcare, Vysioneer. Read More

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bone Health Technology, Danaher. Read More